Spruce Biosciences, Inc. (SPRB) — 8-K Filings

8-K Filings (19)

• Spruce Biosciences Relocates HQ, Hints at Officer Changes — Dec 15, 2025 Risk: medium
  Spruce Biosciences, Inc. announced on December 11, 2025, a change in its principal executive offices to 611 Gateway Boulevard, Suite 740, South San Francisco, C
• Spruce Biosciences Announces Board and Executive Changes — Dec 12, 2025 Risk: medium
  Spruce Biosciences, Inc. announced on December 11, 2025, changes in its board of directors and executive compensation arrangements. The filing details the depar
• 8-K Filing — Nov 10, 2025
• Spruce Biosciences Announces Board and Compensation Changes — Oct 17, 2025 Risk: medium
  Spruce Biosciences, Inc. announced on October 15, 2025, changes in its board of directors and executive compensation arrangements. The filing details the depart
• Spruce Biosciences Files 8-K — Oct 8, 2025 Risk: medium
  On October 7, 2025, Spruce Biosciences, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities
• Spruce Biosciences Files 8-K on Security Holder Matters — Jul 24, 2025 Risk: medium
  Spruce Biosciences, Inc. filed an 8-K on July 24, 2025, reporting events as of July 22, 2025. The filing indicates material modifications to security holder rig
• Spruce Biosciences Faces Delisting Concerns — Jun 12, 2025 Risk: high
  Spruce Biosciences, Inc. filed an 8-K on June 12, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company'
• Spruce Biosciences Files 8-K with Key Corporate Updates — May 29, 2025 Risk: medium
  On May 28, 2025, Spruce Biosciences, Inc. filed an 8-K report detailing several significant events. These include entering into a material definitive agreement,
• Spruce Biosciences Files 8-K on Delisting and Exit Costs — Apr 25, 2025 Risk: high
  Spruce Biosciences, Inc. filed an 8-K on April 25, 2025, reporting on cost-associated exit or disposal activities, and a notice of delisting or failure to meet
• Spruce Biosciences Files 8-K on Financials — Apr 1, 2025 Risk: low
  Spruce Biosciences, Inc. filed an 8-K on April 1, 2025, reporting on its results of operations and financial condition as of March 31, 2025. The filing includes
• Spruce Biosciences Relocates Principal Executive Offices — Dec 27, 2024 Risk: low
  Spruce Biosciences, Inc. announced on December 20, 2024, a change in its principal executive offices to 611 Gateway Boulevard, Suite 740, South San Francisco, C
• Spruce Biosciences Files Routine 8-K — Dec 10, 2024 Risk: low
  On December 10, 2024, Spruce Biosciences, Inc. filed an 8-K report. The filing does not contain specific details about new events, material agreements, or finan
• Spruce Biosciences Faces Delisting Concerns — Oct 28, 2024 Risk: high
  Spruce Biosciences, Inc. filed an 8-K on October 28, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The earli
• Spruce Biosciences Files 8-K for Material Agreement — Jun 18, 2024 Risk: medium
  On June 13, 2024, Spruce Biosciences, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The compan
• Spruce Biosciences Files 8-K — Jun 3, 2024 Risk: low
  Spruce Biosciences, Inc. filed an 8-K on June 3, 2024, reporting an event that occurred on June 2, 2024. The filing is categorized under 'Other Events' and does
• Spruce Biosciences Files 8-K on Shareholder Vote — May 24, 2024 Risk: low
  Spruce Biosciences, Inc. filed an 8-K on May 24, 2024, reporting on a matter submitted to a vote of security holders on May 22, 2024. The filing details the com
• Spruce Biosciences Faces Delisting Concerns — Apr 30, 2024 Risk: high
  Spruce Biosciences, Inc. filed an 8-K on April 30, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, incorporat
• Spruce Biosciences Files 8-K on Operations and Exit Activities — Mar 13, 2024 Risk: medium
  Spruce Biosciences, Inc. filed an 8-K on March 13, 2024, reporting on events as of March 10, 2024. The filing pertains to results of operations, cost associated
• Spruce Biosciences Files 8-K: Routine Corporate Info Update — Jan 8, 2024
  Spruce Biosciences, Inc. filed an 8-K on January 8, 2024, reporting an event that occurred on January 4, 2024. This filing indicates a routine update regarding

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX